Celecoxib
Sold as Celebrex, Cecoxela, Celecoxib unicorn, Coxleon, Celecoxib adco, Celecoxib restan, Celecoxib ran, Exultibrex, Inflasib, Novabrex, Celexii, Albrex, Celecoxib ascendis, Celecoxib LHC, Lexib, Celoxpan, Xibecil, Quloxib, Celecoxib unimed, Procib, Bixicleod
4-[5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
Drag to rotate. Structure from PubChem CID 2662.
Background
Registration
- Applicants
- 15
- Registrations
- 40
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) Ltd | Celebrex | 100, 200 | 330332, 330333 | S3 | None |
| Viatris South Africa (Pty) Ltd | Cecoxela | 100 mg, 200 mg | 450902, 450903 | S3 | None |
| Sandoz South Africa (Pty) Ltd | Celecoxib unicorn, Coxleon, Quloxib | 100, 200 | 460702, 460703, 460704.702, 460705.703, 560924 | S3 | None |
| Adcock ingram limited | Celecoxib adco, Celecoxib restan | 100, 200 | 470982, 470983, 470984.982, 470985.983 | S3 | None |
| Ranbaxy Pharmaceutical (Pty) Ltd | Celecoxib ran | 100, 200 | 480643.645, 480644.646 | S3 | None |
| Accord Healthcare (Pty) Ltd | Exultibrex | 100 MG, 200 MG | 490344, 490345 | S3 | None |
| Ascendis Pharma (Pty) Ltd | Inflasib, Celecoxib ascendis | 100, 200 | 490426, 490427, 530015, 530016 | S3 | None |
| Novagen Pharma (Pty) LtdCancelled | Novabrex | 100, 200 | 500744, 500745 | S3 | None |
| Activo Health (Pty) LtdCertificate held by Forrester Pharma (Pty) Ltd | Celexii | 100, 200 | 509029, 509030 | S3 | PIPIL |
| Innovata pharmaceuticalsCancelled | Albrex | 100 | 510724.722 | S3 | None |
| LHC Pharmaceuticals (Pty) Ltd | Celecoxib LHC | 100 mg, 200 mg | 530459, 530460 | S3 | None |
| Ruby Pharmaceuticals (Pty) Ltd | Lexib | 100, 200 | 540039, 540040 | S3 | None |
| Austell Pharmaceuticals (Pty) Ltd | Celoxpan, Xibecil | 100, 200 | 550613, 550614, 550615.613, 550616.614 | S3 | None |
| Unimed Healthcare (Pty) Ltd | Celecoxib unimed, Procib | 100, 200 | 570620, 570621, 570622.620, 570623.621 | S3 | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Bixicleod | 100, 200 | 580053, 580054 | S3 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Celebrex 100 EACH CAPSULE CONTAINS CELECOXIB 100 mg | 100 | 33033233/3.1/0332 | Registered | S3 | None |
| Celebrex 200 EACH CAPSULE CONTAINS CELECOXIB 200 mg | 200 | 33033333/3.1/0333 | Registered | S3 | None |
| Cecoxela 100 MG EACH CAPSULE CONTAINS: CELECOXIB 100,0 mg | 100 mg | 45090245/3.1/0902 | Registered | S3 | None |
| Cecoxela 200 MG EACH CAPSULE CONTAINS: CELECOXIB 200,0 m | 200 mg | 45090345/3.1/0903 | Registered | S3 | None |
| Celecoxib unicorn 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 46070246/3.1/0702 | Registered | S3 | None |
| Celecoxib unicorn 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 46070346/3.1/0703 | Registered | S3 | None |
| Coxleon 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 460704.70246/3.1/0704.702 | Registered | S3 | None |
| Coxleon 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 460705.70346/3.1/705.703 | Registered | S3 | None |
| Celecoxib 100 adco Each capsule contains CELECOXIB 100,0 mg | 100 | 47098247/3.1/0982 | Registered | S3 | None |
| Celecoxib 200 adco Each capsule contains CELECOXIB 200,0 mg | 200 | 47098347/3.1/0983 | Registered | S3 | None |
| Celecoxib 100 restan Each capsule contains CELECOXIB 100,0 mg | 100 | 470984.98247/3.1/0984.982 | Registered | S3 | None |
| Celecoxib 200 restan Each capsule contains CELECOXIB 200,0 mg | 200 | 470985.98347/3.1/0985.983 | Registered | S3 | None |
| Celecoxib 100 ran Each capsule contains: Celecoxib 100,0 mg | 100 | 480643.64548/3.1/0643.645 | Registered | S3 | None |
| Celecoxib 200 ran Each capsule contains: Celecoxib 200,0 mg | 200 | 480644.64648/3.1/0644.646 | Registered | S3 | None |
| Exultibrex 100 MG Each capsule contains CELECOXIB 100,0 mg | 100 MG | 49034449/3.1/0344 | Registered | S3 | None |
| Exultibrex 200 MG Each capsule contains CELECOXIB 200,0 mg | 200 MG | 49034549/3.1/0345 | Registered | S3 | None |
| Inflasib 100 Each capsule contains CELECOXIB 100,0 mg | 100 | 49042649/3.1/0426 | Registered | S3 | None |
| Inflasib 200 Each capsule contains CELECOXIB 200,0 mg | 200 | 49042749/3.1/0427 | Registered | S3 | None |
| Novabrex 100 EACH CAPSULE CONTAINS: CELECOXIB 100,0 mg | 100 | 50074450/3.1/0744 | Cancelled | S3 | None |
| Novabrex 200 EACH CAPSULE CONTAINS: CELECOXIB 200,0 mg | 200 | 50074550/3.1/0745 | Cancelled | S3 | None |
| Celexii 100 EACH CAPSULE CONTAINS: CELECOXIB 100,0 mg | 100Hard gelatine capsules | 50902950/3.1/9029Approved 20 November 2023 | Registered | S3 | PIPIL |
| Celexii 200 EACH CAPSULE CONTAINS: CELECOXIB 200,0 mg | 200Hard gelatine capsules | 50903050/3.1/9030Approved 20 November 2023 | Registered | S3 | PIPIL |
| Albrex 100 Each Capsule contains: Celecoxib 100,0 mg | 100 | 510724.72251/3.1/0724.722 | Cancelled | S3 | None |
| Celecoxib 100 ascendis EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 53001553/3.1/0015 | Registered | S3 | None |
| Celecoxib 200 ascendis EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 53001653/3.1/0016 | Registered | S3 | None |
| Celecoxib 100 MG LHC EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 mg | 53045953/3.1/0459 | Registered | S3 | None |
| Celecoxib 200 MG LHC EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 mg | 53046053/3.1/0460 | Registered | S3 | None |
| Lexib 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 54003954/3.1/0039 | Registered | S3 | None |
| Lexib 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 54004054/3.1/0040 | Registered | S3 | None |
| Celoxpan 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 55061355/3.1/0613 | Registered | S3 | None |
| Celoxpan 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 55061455/3.1/0614 | Registered | S3 | None |
| Xibecil 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 550615.61355/3.1/0615.613 | Registered | S3 | None |
| Xibecil 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 550616.61455/3.1/0616.614 | Registered | S3 | None |
| Quloxib 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 56092456/3.1/0924 | Registered | S3 | None |
| Celecoxib 100 unimed EACH CAPSULE CONTAINS: CELECOXIB 100,0 mg | 100 | 57062057/3.1/0620 | Registered | S3 | None |
| Celecoxib 200 unimed EACH CAPSULE CONTAINS: CELECOXIB 200,0 mg | 200 | 57062157/3.1/0621 | Registered | S3 | None |
| Procib 100 EACH CAPSULE CONTAINS: CELECOXIB 100,0 mg | 100 | 570622.62057/3.1/0622.620 | Registered | S3 | None |
| Procib 200 EACH CAPSULE CONTAINS: CELECOXIB 200,0 mg | 200 | 570623.62157/3.1/0623.621 | Registered | S3 | None |
| Bixicleod 100 EACH CAPSULE CONTAINS CELECOXIB 100,0 mg | 100 | 58005358/3.1/0053 | Registered | S3 | None |
| Bixicleod 200 EACH CAPSULE CONTAINS CELECOXIB 200,0 mg | 200 | 58005458/3.1/0054 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Celecoxib
S3: Celecoxib
Consolidated Schedules 06 July 2026, line 3304
Pharmacological class: Antirheumatics (anti-inflammatory agents). (class 3.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Celexii 100, Activo Health (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.